Ledger.Open graph →

SEC Form D · filed November 23, 2021

Acrivon Therapeutics, Inc

Offering

$100.0M

Sold

$100.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Watertown, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Eric Devroe · Cambridge, MAExec Peter Blume-Jensen · Cambridge, MAExec · Director Sharon Shacham · Newton, MADirector Kristina Masson · Cambridge, MAExec · Director Derek Dirocco · South San Francisco, CADirector Marcin Czernik · Cambridge, MADirector Erick Gamelin · Watertown, MAExec Peter Blume-Jensen · Cambridge, MAExec · Director Sharon Shacham · Cambridge, MADirector Kristina Masson · Cambridge, MAExec · Director Derek Dirocco · South San Francisco, CADirector Marcin Czernik · Cambridge, MADirector Erick Gamelin · Watertown, MAExec Eric Devroe · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗